Available Globally
Securities Fraud, Hedge Funds, Managed Futures, Economic Damages, Financial Futures, Investment Management, Structured Finance, Finance, Statistics, IPO, Antitrust, Patent Infringement
Dr. Carl Peters, President
Peters and Associates LLC
8582 Yellowstone Road
Longmont, CO 80503
(303)772-2409
ccpeters43@gmail.com
www.petersandassociates.citymax.com
Peters and Associates LLC, Denver (2004 – Present)
President. Expert witness services in Securities Fraud, Hedge Funds,Reg D Offerings, asset management, investments, structured finance, IPO's
Morgan Stanley, New York, NY (1997 – 2004)
Director of Research. Led a team of research scientists in developing investment strategies and financial products for Morgan Stanley.
Abacus Trading Corporation, Pittsburgh, PA (1988 – 1997)
President. Hedge Fund/CTA. Developed proprietary trading technology and managed assets for institutional and high net worth clients.
Westminster College, New Wilmington, PA (1985 –1988)
Endowed Chair in Business and Economics. Taught economics and finance. Served on Board of Directors of the Pennsylvania Economics Association. Named Adjunct Research Associate at Columbia University for research in global financial markets.
College of Business, University of Denver (1977 - 1985)
Chairman, Department of Statistics. Taught in operations research, statistics at the undergraduate and graduate levels as well as the Executive MBA Program.
Weyerhaeuser Company, Tacoma, Washington (1971 –1977)
Assistant to Senior Vice President, International, with resposibilities in corporate planning and project management in Pacific Rim countries.
Education
PhD University of California, Los Angeles( 1971)
Operations Research/Systems/Economics
MS Massachusetts Institute of Technology (1967)
Engineering
BS Pennsylvania State University (1965)
Engineering
Antitrust,Asset Management, Business/Analysis, Business Damages, Economic Damages,Financial Fraud, Financial Futures, Investment Management, Securities Fraud, Hedge Funds, Structured Finance, Finance, Economics, Stocks, bonds, IPO |